Focused analysis reports significant pain relief in diabetic peripheral neuropathy, indicating effective dose optimization regardless of glycemic control.
Pregabalin at 300 and 600 mg/day provides significant pain relief in pDPN, regardless of HbA1c levels, supporting dose optimization to achieve maximal benefit.
No takes yet. Share an insight, caveat, or question.
Bajaj et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: